Although CJI women were generally unaware of PrEP, attitudes toward PrEP were enthusiastic. Of system stakeholders (n = 25), 52% represented the CJ sector. The majority of CJI women (n = 27) were, on average, 41.3 years, from racial and ethnic minority groups (56% Black/African-American 19% Latinx) and reported engaging in recent high-risk behavior (nearly 60% engaged in transactional sex, 22% reported ≥ 4 sexual partners, and 37% reported injection drug use). Data were analyzed using inductive thematic analysis and executive summaries. Interviews explored awareness of PrEP and the multilevel factors shaping PrEP acceptability. Between January 2017 and December 2017, we conducted 52 interviews with CJI women at high risk for HIV and stakeholders from the criminal justice (CJ) and public health (PH) systems. The purpose of this study was to examine multilevel factors shaping PrEP awareness and acceptability among CJI women. MAT programs for people who are criminal justice (CJ) involved may serve as useful linkage spaces to PrEP information, access, and retention.Īlthough pre-exposure prophylaxis (PrEP) is a key tool in HIV prevention efforts, little is known about PrEP as a prevention strategy for criminal justice-involved (CJI) women.
Potential barriers included side effects, adherence, and reluctance to take medications in general. PrEP interest strongly related to current perceived HIV risk. While PrEP awareness was low across the study sample, some participants were interested in PrEP uptake or learning more about PrEP after they were provided with an overview of it. Analysis was conducted using a generalized, inductive method in NVivo 12. The present study assessed HIV risk perceptions as well as PrEP awareness and interest among 39 people who were incarcerated and enrolled in a structured Medication for Addiction Treatment (MAT) program at the Rhode Island Department of Corrections using semi-structured, qualitative interviews. People who are incarcerated are at increased risk for HIV (human immunodeficiency virus) acquisition upon release, and one possible intervention for prevention is the use of pre-exposure prophylaxis (PrEP) upon release.
0 kommentar(er)
